Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant treatment for elderly patients with colon cancer. An observational study.
Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P, Bajetta E, Platania M, Alabiso O, Miraglia S, Bertona E, Oniga F, Biason R, Chetrì MC, Fedele P, Massara G, Romaniello I, Negru ME, Luchena G, Giordano M, Buzzi F, Ricottao R, Sienao S, Monfardini S. Pasetto LM, et al. Among authors: bonginelli p. Anticancer Res. 2008 Jul-Aug;28(4C):2513-8. Anticancer Res. 2008. PMID: 18751443 Free article.
Colorectal cancer treatment in elderly patients: results of a retrospective analysis addressed to the chiefs of medical oncology units in Italy.
Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P, Bajetta E, Platania M, Alabisio O, Miraglia S, Bertona E, Oniga F, Biason R, Chetrì MC, Fedele P, Massara G, Romaniello I, Negru ME, Giordano M, Luchena G, Buzzi F, Ricotta R, Siena S, Monfardini S. Pasetto LM, et al. Among authors: bonginelli p. Anticancer Res. 2007 Sep-Oct;27(5B):3601, 3603-8. Anticancer Res. 2007. PMID: 17972523 Free article.
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.
Gasparini G, Meo S, Comella G, Stani SC, Mariani L, Gamucci T, Avallone A, Lo Vullo S, Mansueto G, Bonginelli P, Gattuso D, Gion M. Gasparini G, et al. Among authors: bonginelli p. Cancer J. 2005 May-Jun;11(3):209-16. doi: 10.1097/00130404-200505000-00007. Cancer J. 2005. PMID: 16053664 Clinical Trial.
Antiangiogenic agents.
Stani SC, Capaccetti B, Bonginelli P, Sarmiento R, De Sio L, Fanelli M, Gasparini G. Stani SC, et al. Among authors: bonginelli p. Suppl Tumori. 2002 Jul-Aug;1(4):S39-43. Suppl Tumori. 2002. PMID: 12415816 Review. No abstract available.
[Innovative treatment in oncology].
Capaccetti B, Bonginelli P, Sarmiento R, Fanelli M, Longo R, Gattuso D, Gasparini G. Capaccetti B, et al. Among authors: bonginelli p. Recenti Prog Med. 2002 Nov;93(11):602-9. Recenti Prog Med. 2002. PMID: 12489478 Review. Italian.
12 results